The Effects of Wumei Pill on Intestinal Flora and Neurotransmitters in Rats with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

被引：1
|
作者：
Ding, Xiaojie [1 ]
Sun, Xiling [1 ]
Yu, Xiaofei [1 ]
Zhao, Shutian [1 ]
Yang, Yi [1 ]
Xu, Wenjuan [1 ]
Wang, Kejun [1 ]
Zou, Xiaolan [1 ]
Dong, Zhengping [1 ]
机构：
[1] Binzhou Med Univ, Sch Integrated Chinese Tradit & Western Med, Yantai 264003, Shandong, Peoples R China
来源：
2018 INTERNATIONAL CONFERENCE ON BIOTECHNOLOGY AND BIOENGINEERING (8TH ICBB) | 2019年 / 2079卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1063/1.5092406
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The objective is to investigate the effects of Wumei Pill on intestinal flora and neurotransmitters in rats with diarrhea-predominant irritable bowel syndrome (IBS-D). Method: The model was established by means of acetic acid enema plus restraint stress. The rat fecal moisture content, fecal trait score, and abdominal wall withdrawal reflex (AWR) score were used to determine whether the model was successful. Evaluated the Wumei Pills effect on rat fecal moisture content, fecal trait score, AWR score, Bifidobacterium/Enterobacteriaceae (B/E) value, and hippocampal tissue glutamate (Glu) and gamma-aminobutyric acid (gamma-GABA), dopamine (DA), 5-hydroxytryptamine (5-HT) content. Results: (1) the rat IBS-D model was successfully prepared; (2) Wumei Pill could reduce the fecal moisture content, fecal trait score, AWR score (P< 0.05), and alleviate the symptoms of rat diarrhea; (3) Wumei Pills can increase the rats B/E value (P< 0.05) increase the intestinal colonization resistance in rats. (4) Wumei Pills can reduce the contents of Glu, gamma-GABA, DA and 5-HT in the hippocampus of rats (P< 0.05), and have a certain regulatory effect on neurotransmitters in the rat brain. Conclusion: Wumei Pill has a significant therapeutic effect on IBS-D, and the mechanism may be related to the regulation of intestinal flora and neurotransmitters.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] The Effects of Wumei Pill on TLRs/NF-kB Signaling Pathway in Rats with Diarrhea-Predominant Irritable Bowel Syndrome
    Ding, Xiaojie
    Sun, Xiling
    Wang, Zuien
    Zheng, Qiusheng
    Yu, Xiaofei
    Hao, Wenjin
    Wang, Kejun
    Xu, Wenjuan
    Dong, Zhengping
    [J]. PAKISTAN JOURNAL OF ZOOLOGY, 2019, 51 (01) : 57 - 65
  • [2] Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 858 - 858
  • [3] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [4] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [5] AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Carrasco-Labra, Alonso
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    Surawicz, Christina M.
    Chey, William D.
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 859 - 880
  • [6] Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): Fact or fiction
    Habba, Saad F.
    [J]. MEDICAL HYPOTHESES, 2011, 76 (01) : 97 - 99
  • [7] Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?
    Xu, Xiao-juan
    Liu, Liang
    Yao, Shu-kun
    [J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2016, 17 (01): : 1 - 9
  • [8] Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
    Breslin, Henry J.
    Diamond, Craig J.
    Kavash, Robert W.
    Cai, Chaozhong
    Dyatkin, Alexey B.
    Miskowski, Tamara A.
    Zhang, Sui-Po
    Wade, Paul R.
    Hornby, Pamela J.
    He, Wei
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4869 - 4872
  • [9] Stool microbiota characterization in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) receiving repeat Rifaximin
    Pimentel, M.
    Fodor, A. A.
    Golden, P. L.
    Bortey, E.
    Forbes, W. P.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 100 - 100
  • [10] The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors
    Hao Lin
    Qingqing Guo
    Zhiyong Wen
    Songlin Tan
    Jie Chen
    Lijian Lin
    Pengcheng Chen
    Jianquan He
    Jianbo Wen
    Ye Chen
    [J]. Microbial Cell Factories, 20
12345